These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37022608)

  • 1. Artificial intelligence assisted identification of potential tau aggregation inhibitors: ligand- and structure-based virtual screening, in silico ADME, and molecular dynamics study.
    Das B; Mathew AT; Baidya ATK; Devi B; Salmon RR; Kumar R
    Mol Divers; 2024 Aug; 28(4):2013-2031. PubMed ID: 37022608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer's Disease.
    Pradeepkiran JA; Reddy PH
    Cells; 2019 Mar; 8(3):. PubMed ID: 30893872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for inhibitors of tau protein aggregation into Alzheimer paired helical filaments: a ligand based approach results in successful scaffold hopping.
    Larbig G; Pickhardt M; Lloyd DG; Schmidt B; Mandelkow E
    Curr Alzheimer Res; 2007 Jul; 4(3):315-23. PubMed ID: 17627489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
    Liu M; Dexheimer T; Sui D; Hovde S; Deng X; Kwok R; Bochar DA; Kuo MH
    Sci Rep; 2020 Oct; 10(1):16551. PubMed ID: 33024171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiophene-Based Dual Modulators of Aβ and Tau Aggregation.
    Ramesh M; Acharya A; Murugan NA; Ila H; Govindaraju T
    Chembiochem; 2021 Dec; 22(23):3348-3357. PubMed ID: 34546619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.
    El Kerdawy AM; Osman AA; Zaater MA
    J Mol Model; 2019 May; 25(6):171. PubMed ID: 31129879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors.
    Devi B; Vasishta SS; Das B; Baidya ATK; Rampa RS; Mahapatra MK; Kumar R
    Mol Divers; 2024 Apr; 28(2):649-669. PubMed ID: 36745307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease.
    Das B; Tk Baidya A; Chakrabarti S; Chouhan D; Thakur B; Darreh-Shori T; Chen G; Tiwari V; Kumar R
    Bioorg Chem; 2024 Jun; 147():107373. PubMed ID: 38653149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel chemotype as DYRK1A inhibitors against Alzheimer's disease: Computational modeling and biological evaluation.
    Qiu N; Qian C; Guo T; Wang Y; Jin H; Yao M; Li M; Guo T; Lv Y; Si X; Wu S; Wang H; Zhang X; Xia J
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132024. PubMed ID: 38704072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.
    Manzoor S; Gabr MT; Rasool B; Pal K; Hoda N
    Bioorg Chem; 2021 Nov; 116():105354. PubMed ID: 34562674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer's disease.
    Jangid K; Devi B; Sahoo A; Kumar V; Dwivedi AR; Thareja S; Kumar R; Kumar V
    J Biomol Struct Dyn; 2024; 42(1):509-527. PubMed ID: 37114423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations.
    Yazdani B; Sirous H; Enguita FJ; Brogi S; Wing PAC; Fassihi A
    Mol Divers; 2024 Jun; 28(3):1203-1224. PubMed ID: 37120484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics.
    Mouchlis VD; Melagraki G; Zacharia LC; Afantitis A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells.
    Pickhardt M; Larbig G; Khlistunova I; Coksezen A; Meyer B; Mandelkow EM; Schmidt B; Mandelkow E
    Biochemistry; 2007 Sep; 46(35):10016-23. PubMed ID: 17685560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.
    Zhang W; Smith N; Zhou Y; McGee CM; Bartoli M; Fu S; Chen J; Domena JB; Joji A; Burr H; Lv G; Cilingir EK; Bedendo S; Claure ML; Tagliaferro A; Eliezer D; Veliz EA; Zhang F; Wang C; Leblanc RM
    Acta Biomater; 2024 Jul; 183():341-355. PubMed ID: 38849023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel PARP-1 inhibitors using tandem
    Bhatnagar A; Nath V; Kumar N; Kumar V
    J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.